Product
AXS-07
3 clinical trials
1 indication
Indication
MigraineClinical trial
An Open-Label, Multiple-Dose Evaluation of the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP InhibitorStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
MOMENTUM: A Randomized, Double-blind, Single-dose, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in AdultsStatus: Completed, Estimated PCD: 2019-12-10
Clinical trial
An Open-Label, Long-Term Study to Assess the Safety and Efficacy of AXS-07 (MoSEIC™ Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in AdultsStatus: Completed, Estimated PCD: 2020-09-22